Ruiqin Yuan (瑞秦源)瑞秦源
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司
主要成分Active Ingredients
- 果糖 葡萄糖Recorded Chinese composition: 果糖 葡萄糖
- 果糖Guo Tang
- 葡萄糖Putao Tang
药物知识说明
果糖 葡萄糖是一种在国家药监局注册认定的药品。该药品含有果糖、葡萄糖-31b6cd73等成分。
该药品关联的活性成分包括：果糖Guo Tang、葡萄糖Putao Tang。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司。
您可以探索含有相同成分的其他药品：果糖-aa933231成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 瑞秦源) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 果糖Guo Tang, 葡萄糖Putao Tang.
Manufacturers recorded for this product: 海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司.
Explore other medicines containing the same ingredient: 果糖 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 瑞秦源Recorded Chinese name: 瑞秦源
- 剂型Dosage form: 注射剂Injection
- 规格Specification: （1）果糖6.25g与葡萄糖6.25g。（2）果糖12.5g与葡萄糖12.5gRecorded Chinese description: （1）果糖6.25g与葡萄糖6.25g。（2）果糖12.5g与葡萄糖12.5g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 海南灵康制药有限公司Chinese legal name: 海南灵康制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20060415
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20060415
Manufacturer
Chinese legal name: 海南灵康制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20060415
生产企业
海南灵康制药有限公司(国产)
适应症
适用于需要非口服途径补充能量的患者。尤其是下列情况：1）糖尿病患者的能量补充。2）烧创伤、术后及感染等胰岛素抵抗（糖尿病状态）患者的能量补充。3）药物中毒。4）酒精中毒。
用法用量
静脉滴注，用前每支用注射用水250ml溶解稀释，成人常用量为每次250～1000ml，滴注速度应低于0.5g/kg/hr（以果糖计）。用量视病情需要而定。
不良反应
据报道，可能会引起脸红、风疹、发热等过敏反应。
大剂量、快速输注可能会导致乳酸中毒和高尿酸血症。长期单纯使用可引起电解质紊乱。
禁忌
遗传性果糖不耐受患者禁用，痛风和高尿酸血症患者禁用。
警告：应警惕本品过量使用或不正确使用有可能引起危及生命的乳酸性酸中毒，未诊断的遗传性果糖不耐受症患者使用本品时可能有致命的危险。
贮藏
遮光，密闭保存。
规格
（1）果糖6.25g与葡萄糖6.25g。（2）果糖12.5g与葡萄糖12.5g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.